Health Catalyst Management
Management criteria checks 2/4
Health Catalyst's CEO is Dan Burton, appointed in Oct 2012, has a tenure of 12.58 years. total yearly compensation is $5.49M, comprised of 9.6% salary and 90.4% bonuses, including company stock and options. directly owns 1.44% of the company’s shares, worth $4.06M. The average tenure of the management team and the board of directors is 2.3 years and 5.3 years respectively.
Key information
Dan Burton
Chief executive officer
US$5.5m
Total compensation
| CEO salary percentage | 9.56% |
| CEO tenure | 12.6yrs |
| CEO ownership | 1.4% |
| Management average tenure | 2.3yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
Health Catalyst, Inc. (NASDAQ:HCAT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 09
Ignite Transition And Recent Acquisitions Will Expand Global Footprint
Mar 30 Cross-selling through the Ignite platform is projected to boost client additions and accelerate revenue growth.Health Catalyst: Share Price Continues To Dismiss Positive Earnings And Improved Outlook
Mar 25Take Care Before Jumping Onto Health Catalyst, Inc. (NASDAQ:HCAT) Even Though It's 27% Cheaper
Mar 08Health Catalyst (NASDAQ:HCAT) Has Debt But No Earnings; Should You Worry?
Feb 27It's A Story Of Risk Vs Reward With Health Catalyst, Inc. (NASDAQ:HCAT)
Jan 15Health Catalyst: Improved Demand Environment Reinforces My Buy Rating
Dec 18Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
Sep 24Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business
Jul 17Health Catalyst: Stellar Earnings Growth Projected
Jun 26Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price
Apr 04Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Mar 09Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)
Feb 16Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jan 27What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You
Dec 24Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?
Dec 15Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?
Oct 24Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price
Jul 31Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Jun 27Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Feb 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$73m |
| Dec 31 2024 | US$5m | US$525k | -US$70m |
| Sep 30 2024 | n/a | n/a | -US$79m |
| Jun 30 2024 | n/a | n/a | -US$86m |
| Mar 31 2024 | n/a | n/a | -US$106m |
| Dec 31 2023 | n/a | n/a | -US$118m |
| Sep 30 2023 | n/a | n/a | -US$124m |
| Jun 30 2023 | n/a | n/a | -US$147m |
| Mar 31 2023 | n/a | n/a | -US$148m |
| Dec 31 2022 | US$4m | US$150k | -US$137m |
| Sep 30 2022 | n/a | n/a | -US$151m |
| Jun 30 2022 | n/a | n/a | -US$145m |
| Mar 31 2022 | n/a | n/a | -US$147m |
| Dec 31 2021 | US$6m | US$300k | -US$153m |
| Sep 30 2021 | n/a | n/a | -US$147m |
| Jun 30 2021 | n/a | n/a | -US$135m |
| Mar 31 2021 | n/a | n/a | -US$126m |
| Dec 31 2020 | US$5m | US$315k | -US$115m |
| Sep 30 2020 | n/a | n/a | -US$86m |
| Jun 30 2020 | n/a | n/a | -US$99m |
| Mar 31 2020 | n/a | n/a | -US$181m |
| Dec 31 2019 | US$4m | US$350k | -US$241m |
| Sep 30 2019 | n/a | n/a | -US$304m |
| Jun 30 2019 | n/a | n/a | -US$282m |
| Mar 31 2019 | n/a | n/a | -US$190m |
| Dec 31 2018 | US$5m | US$315k | -US$114m |
Compensation vs Market: Dan's total compensation ($USD5.49M) is above average for companies of similar size in the US market ($USD1.62M).
Compensation vs Earnings: Dan's compensation has increased whilst the company is unprofitable.
CEO
Dan Burton (48 yo)
12.6yrs
Tenure
US$5,494,141
Compensation
Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has strategy and leaders...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 12.6yrs | US$5.49m | 1.44% $ 4.1m | |
| Chief Financial Officer | 1.2yrs | US$1.29m | 0.050% $ 141.7k | |
| General Counsel & Secretary of the Board | 2yrs | US$1.57m | 0% $ 0 | |
| Chief People Officer | 7.3yrs | US$1.41m | 0.043% $ 122.0k | |
| Chief Commercial Officer | no data | US$2.16m | 0.19% $ 525.0k | |
| Chief Operating Officer | 1.2yrs | no data | 0.30% $ 835.7k | |
| Chief Technology Officer | 2.7yrs | no data | no data | |
| Senior Vice President of Marketing & Communications | less than a year | no data | no data | |
| Chief Strategy Officer & Senior VP of Corporate Development | no data | no data | no data | |
| Senior Vice President of International | 6yrs | no data | no data | |
| Senior VP & Chief Clinical Officer | no data | no data | no data | |
| Chief Client Success Officer | no data | no data | no data |
2.3yrs
Average Tenure
46.5yo
Average Age
Experienced Management: HCAT's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 13.7yrs | US$5.49m | 1.44% $ 4.1m | |
| Independent Chairman | 9.3yrs | US$316.16k | 0.16% $ 461.5k | |
| Independent Director | 5.3yrs | US$233.49k | 0.072% $ 204.8k | |
| Independent Director | 5.3yrs | US$237.25k | 0.064% $ 181.3k | |
| Independent Director | 8yrs | US$244.77k | 0.075% $ 211.8k | |
| Director | less than a year | no data | 0.040% $ 112.5k | |
| Independent Director | 1.8yrs | no data | no data |
5.3yrs
Average Tenure
60.5yo
Average Age
Experienced Board: HCAT's board of directors are considered experienced (5.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 10:01 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Health Catalyst, Inc. is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhilin Long | Berenberg |
| David Larsen | BTIG |
| Richard Close | Canaccord Genuity |